Xiyu Ding

Shijia Zhang, Xiyu Ding, Kai Ding et al.

Identifying immune checkpoint inhibitor (ICI) studies in genomic repositories like Gene Expression Omnibus (GEO) is vital for cancer research yet remains challenging due to semantic ambiguity, extreme class imbalance, and limited labeled data in low-resource settings. We present ProtoBERT-LoRA, a hybrid framework that combines PubMedBERT with prototypical networks and Low-Rank Adaptation (LoRA) for efficient fine-tuning. The model enforces class-separable embeddings via episodic prototype training while preserving biomedical domain knowledge. Our dataset was divided as: Training (20 positive, 20 negative), Prototype Set (10 positive, 10 negative), Validation (20 positive, 200 negative), and Test (71 positive, 765 negative). Evaluated on test dataset, ProtoBERT-LoRA achieved F1-score of 0.624 (precision: 0.481, recall: 0.887), outperforming the rule-based system, machine learning baselines and finetuned PubMedBERT. Application to 44,287 unlabeled studies reduced manual review efforts by 82%. Ablation studies confirmed that combining prototypes with LoRA improved performance by 29% over stand-alone LoRA.

Shijia Zhang, Xiyu Ding, Brian Caffo et al.

Early diagnosis of Alzheimer's disease (AD) is critical for intervention before irreversible neurodegeneration occurs. Structural MRI (sMRI) is widely used for AD diagnosis, but conventional deep learning approaches primarily rely on intensity-based features, which require large datasets to capture subtle structural changes. Jacobian determinant maps (JSM) provide complementary information by encoding localized brain deformations, yet existing multimodal fusion strategies fail to fully integrate these features with sMRI. We propose a cross-attention fusion framework to model the intrinsic relationship between sMRI intensity and JSM-derived deformations for AD classification. Using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, we compare cross-attention, pairwise self-attention, and bottleneck attention with four pre-trained 3D image encoders. Cross-attention fusion achieves superior performance, with mean ROC-AUC scores of 0.903 (+/-0.033) for AD vs. cognitively normal (CN) and 0.692 (+/-0.061) for mild cognitive impairment (MCI) vs. CN. Despite its strong performance, our model remains highly efficient, with only 1.56 million parameters--over 40 times fewer than ResNet-34 (63M) and Swin UNETR (61.98M). These findings demonstrate the potential of cross-attention fusion for improving AD diagnosis while maintaining computational efficiency.

Xin Su, Timothy Miller, Xiyu Ding et al.

Automatic phenotyping is a task of identifying cohorts of patients that match a predefined set of criteria. Phenotyping typically involves classifying long clinical documents that contain thousands of tokens. At the same time, recent state-of-art transformer-based pre-trained language models limit the input to a few hundred tokens (e.g. 512 tokens for BERT). We evaluate several strategies for incorporating pre-trained sentence encoders into document-level representations of clinical text, and find that hierarchical transformers without pre-training are competitive with task pre-trained models.

Dianbo Liu, Leonardo Clemente, Canelle Poirier et al.

We present a timely and novel methodology that combines disease estimates from mechanistic models with digital traces, via interpretable machine-learning methodologies, to reliably forecast COVID-19 activity in Chinese provinces in real-time. Specifically, our method is able to produce stable and accurate forecasts 2 days ahead of current time, and uses as inputs (a) official health reports from Chinese Center Disease for Control and Prevention (China CDC), (b) COVID-19-related internet search activity from Baidu, (c) news media activity reported by Media Cloud, and (d) daily forecasts of COVID-19 activity from GLEAM, an agent-based mechanistic model. Our machine-learning methodology uses a clustering technique that enables the exploitation of geo-spatial synchronicities of COVID-19 activity across Chinese provinces, and a data augmentation technique to deal with the small number of historical disease activity observations, characteristic of emerging outbreaks. Our model's predictive power outperforms a collection of baseline models in 27 out of the 32 Chinese provinces, and could be easily extended to other geographies currently affected by the COVID-19 outbreak to help decision makers.